When Impact Multiplies: Defining Trials and Insights from the 2025 Society of Gynecologic Oncology Annual Meeting.

IF 4.1 2区医学 Q1 OBSTETRICS & GYNECOLOGY

International Journal of Gynecological Cancer Pub Date : 2025-04-22 DOI:10.1016/j.ijgc.2025.101895

Mariana Carvalho Gouveia, Jéssica Monteiro Vasconcellos, Letícia Vecchi Leis, Mariana Scaranti

引用次数: 0

Abstract

"When Impact Multiplies: Defining Trials and Insights From the 2025 Society of Gynecologic Oncology Annual Meeting" features the most significant and potentially practice-changing research presented at the Annual Meeting on Women's Cancer. Held in Seattle, WA from March 14 to 17, 2025, the Society of Gynecologic Oncology Annual Meeting remains one of the premier conferences for professionals dedicated to advancing gynecologic cancer care. The scientific program covered a broad spectrum of topics across gynecologic oncology, highlighting the latest advancements in research, clinical practice, and patient-centered care. From this comprehensive program, we selected 14 studies considered to be highly impactful.

查看原文本刊更多论文

当影响倍增：2025年妇科肿瘤学会年会的定义试验和见解。

“当影响倍增：2025年妇科肿瘤学会年会的定义试验和见解”介绍了在女性癌症年会上提出的最重要和可能改变实践的研究。妇科肿瘤学会年会于2025年3月14日至17日在华盛顿州西雅图举行，是致力于推进妇科癌症护理的专业人士的首要会议之一。科学计划涵盖了妇科肿瘤学的广泛主题，突出了研究、临床实践和以患者为中心的护理方面的最新进展。从这个综合项目中，我们选择了14项被认为具有高度影响力的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Gynecological Cancer 医学-妇产科学

CiteScore

6.60

自引率

10.40%

发文量

280

审稿时长

3-6 weeks

期刊介绍： The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.